The role of dissolution testing in the design of immediate release dosage forms

Drug Information Journal

Volumn 30, Issue 4, 1996, Pages 1039-1044

  Storey, David E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Design; Dissolution testing; Formulation team; Immediate release dosage forms

Indexed keywords

EXCIPIENT;

AQUEOUS SOLUTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DESIGN; DRUG DEVELOPMENT; DRUG DOSAGE FORM; DRUG DOSE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; GEL; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHARMACEUTICS; PHARMACOKINETICS; POWDER; PRIORITY JOURNAL; REVIEW; TABLET; TABLET DISINTEGRATION;

EID: 0029806819     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000420     Document Type: Review

References (4)

1. Murthy KS, Ghebre-Sellassie I. Current Perspectives on the Dissolution Stability of Solid Oral Dosage Forms. J Pharma Sci. 1993;82:113-126.
2. Simmons DL, Legore AA, Picotte P, Leeks, Joshi NN. A Dissolution Rate Apparatus for the Prediction of Initial Drug Absorption Patterns in Beagles: Tolbutamide Tablets. J Pharmacokin Biopharma. 1975;3(1): 39-49.
3. Hersey JA. Methods Available for the Determination of In vitro Dissolution Rate. Manufac Chem Aerosol News. 1969;40:32-35.
4. Dakkuri A, Shah A. Dissolution Methodology, An Overview. Pharma Tech. 1982;28-46.